Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2019 13:17 ET | Source: DrugCendR Inc.

DrugCendR Inc. Announces the Appointment of Dr. Daniel Von Hoff as Clinical Advisor

LA JOLLA, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- DrugCendR, Inc., a clinical-stage biotech company developing next generation therapies for the treatment of solid tumors, today announced that Dr....